| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/30/1999 | EP0925366A1 Methods for producing carotenoid compounds and speciality oils in plant seeds |
| 06/30/1999 | EP0925362A2 Transgenic plants expressing cellulolytic enzymes |
| 06/30/1999 | EP0925360A1 Angiogenic factor and use thereof in treating cardiovascular disease |
| 06/30/1999 | EP0925358A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use |
| 06/30/1999 | EP0925357A1 Human cns cell lines and methods of use therefor |
| 06/30/1999 | EP0925356A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 06/30/1999 | EP0925307A1 Enzyme and dna sequence encoding same |
| 06/30/1999 | EP0925077A2 Graft prosthesis, materials and methods |
| 06/30/1999 | EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 06/30/1999 | EP0925067A1 Composition and method for repairing neurological tissue |
| 06/30/1999 | EP0924986A1 Antioxidant derived from lentil and its preparation and uses |
| 06/30/1999 | CN1221492A Method of enriching rare cells |
| 06/30/1999 | CN1221456A 'alpha' 2 subunit of prolyl-4-hydroxylase, nucleic acid sequences encoding such subunit and methods for producing the same |
| 06/30/1999 | CN1221454A Regulating metabolism by modifying level of trehalose-6-phosphate |
| 06/30/1999 | CN1221452A Hybrid interferon compositions and method of use |
| 06/30/1999 | CN1221449A Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 06/30/1999 | CN1221345A Isolated necleic acid molecules which code for GAGE tumor rejection antigen, the tumor rejection antigen, and uses thereof |
| 06/30/1999 | CN1221033A Oncogene- or virus-controlled expression systems |
| 06/29/1999 | US5917128 Cytoplasmic male sterile brassica oleracea plant, and method for obtaining such plant |
| 06/29/1999 | US5917126 Saccharose phosphate synthetase (SPS), a preparation method and CDNA therefor, and use of the CDNA for modifying SPS expression in plant cells |
| 06/29/1999 | US5917027 Nucleic acids encoding potassium-channel proteins |
| 06/29/1999 | US5916870 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 06/29/1999 | US5916809 Medium for culturing normal human epidermal melanocytes |
| 06/29/1999 | US5916808 Hybridizing to pre-messenger rna at splice element of native intron, thus creating duplex and permitting splicing; oligonucleotide does not activate rnaase h and blocks mutant splice elements; treatment of beta-thalassemia |
| 06/29/1999 | US5916805 Antithrombotic agent and anti-von Willebrand factor monoclonal antibody |
| 06/29/1999 | US5916793 Arginine deiminase derived from Mycoplasma arthritidis and polymer conjugates containing the same |
| 06/29/1999 | US5916792 Jak3 plays a role in the growth factor modulated differentiation/proliferation of the stem/progenitor cells. |
| 06/29/1999 | US5916790 Encapsulation compositions, and methods |
| 06/29/1999 | US5916773 Recombinant production of fusion proteins comprising erythropoietin and GM-CSF components |
| 06/29/1999 | US5916771 One advantage of the method of the invention is that cells expressing a single component of the final multi-component protein can be individually selected for one or more desired characteristics, such as a high rate of production. |
| 06/29/1999 | US5916770 Macrophage stimulating protein variant and method for producing the same |
| 06/29/1999 | US5916769 Polynucleotides encoding extra cellular/epidermal growth factor HCABA58X polypepides |
| 06/29/1999 | US5916767 DNA encoding human interleukin-5 receptor |
| 06/29/1999 | US5916766 Human marco scavenger receptor |
| 06/29/1999 | US5916760 IKK-β proteins, nucleic acids and methods |
| 06/29/1999 | US5916755 Relates to genes which encode novel proteins related to a family of receptor proteins typified by two related membrane spanning tyrosine kinases: the epidermal growth factor receptor, which is encoded by the erbb gene, and the receptor |
| 06/29/1999 | US5916743 Continuous process for the separation of biologic components from heterogeneous cell populations |
| 06/29/1999 | US5916572 Chagas' disease |
| 06/29/1999 | US5916561 Monoclonal antibody against CD44v6 |
| 06/29/1999 | US5916557 Methods of repairing connective tissues |
| 06/29/1999 | US5916556 Human MRNA editing enzyme |
| 06/29/1999 | US5916554 Insulin |
| 06/29/1999 | CA1340611C Recombinant alveolar surfactant protein |
| 06/29/1999 | CA1340610C Monoclonal antibody to polymorphic hla determinant-b27 |
| 06/24/1999 | WO1999031509A1 Improved method for the identification and characterization of interacting molecules using automation |
| 06/24/1999 | WO1999031255A2 Novel egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes |
| 06/24/1999 | WO1999031254A1 Geranyl diphosphate synthase genes |
| 06/24/1999 | WO1999031252A1 Ubiquitin-like conjugating protein |
| 06/24/1999 | WO1999031251A1 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 06/24/1999 | WO1999031246A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 06/24/1999 | WO1999031241A1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| 06/24/1999 | WO1999031240A2 14-3-3σ ARRESTS THE CELL CYCLE |
| 06/24/1999 | WO1999031236A2 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 06/24/1999 | WO1999031234A1 Human rad1 nucleic acid, polypeptides, assays, therapeutic methods and means |
| 06/24/1999 | WO1999031233A1 Polypeptides, polynucleotides and uses thereof |
| 06/24/1999 | WO1999031232A1 Human brain derived kcnq2 potassium channel |
| 06/24/1999 | WO1999031231A1 p53 REGULATORY PROTEIN CALLED RB18A AND USES THEREOF |
| 06/24/1999 | WO1999031230A2 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | WO1999031229A2 Peptides and nucleic acids derived from eisenia foetida and the use thereof |
| 06/24/1999 | WO1999031226A1 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 06/24/1999 | WO1999031225A2 Human phosphatases |
| 06/24/1999 | WO1999031223A1 Industrial production of meat from in vitro cell cultures |
| 06/24/1999 | WO1999031222A1 Industrial scale production of meat from in vitro cell cultures |
| 06/24/1999 | WO1999031221A1 Chondrocyte-like cells useful for tissue engineering and methods |
| 06/24/1999 | WO1999031219A2 Method for decomposing biological material |
| 06/24/1999 | WO1999031139A1 Novel monoclonal antibodies and utilization thereof |
| 06/24/1999 | WO1999031134A1 Glucose regulated gene |
| 06/24/1999 | WO1999031133A1 Novel abc transporter |
| 06/24/1999 | WO1999031130A1 Galanin receptor galr3 and nucleotides encoding same |
| 06/24/1999 | WO1999031129A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1 |
| 06/24/1999 | WO1999031128A2 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | WO1999031117A1 110 human secreted proteins |
| 06/24/1999 | WO1999031116A1 Human dendriac and brainiac-3 |
| 06/24/1999 | WO1999030743A1 Methods for evaluating a compound for its effect on skin |
| 06/24/1999 | WO1999030738A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | WO1999030735A1 UGC (UPSTREAM GENE OF cdsA) |
| 06/24/1999 | WO1999030730A1 Methods and compositions for improving the success of cell transplantation in a host |
| 06/24/1999 | WO1999030648A1 Pluripotential bone marrow cell line and methods of using the same |
| 06/24/1999 | WO1999019480A3 Human receptor proteins; related reagents and methods |
| 06/24/1999 | WO1999019359A9 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 06/24/1999 | WO1999016888A3 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 06/24/1999 | WO1997030158A9 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 06/24/1999 | CA2348660A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | CA2326694A1 Galanin receptor galr3 and nucleotides encoding same |
| 06/24/1999 | CA2315785A1 Peptides and nucleic acids derived from eisenia foetida and the use thereof |
| 06/24/1999 | CA2315529A1 Dna molecules encoding human nuclear receptor proteins, nnr7 and nnr7-1 |
| 06/24/1999 | CA2315527A1 Human phosphatases |
| 06/24/1999 | CA2315295A1 110 human secreted proteins |
| 06/24/1999 | CA2315275A1 P53 regulatory protein called rb18a and uses thereof |
| 06/24/1999 | CA2315268A1 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | CA2315255A1 Method for disrupting biological material |
| 06/24/1999 | CA2315251A1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| 06/24/1999 | CA2314884A1 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | CA2314609A1 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 06/24/1999 | CA2314379A1 Human dendriac and brainiac-3 |
| 06/24/1999 | CA2314141A1 Glucose regulated gene |
| 06/24/1999 | CA2313448A1 Ubiquitin-like conjugating protein |
| 06/24/1999 | CA2313391A1 Human rad1 nucleic acid, polypeptides, assays, therapeutic methods and means |
| 06/24/1999 | CA2311896A1 Improved method for the identification and characterization of interacting molecules using automation |
| 06/24/1999 | CA2311572A1 Extended cdnas for secreted proteins |